BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.47B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.89B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$708M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$524M |
| 5 |
Nike
NKE
|
+$468M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
+$293M |
| 3 |
SPDR S&P Retail ETF
XRT
|
+$148M |
| 4 |
NVIDIA
NVDA
|
+$74.9M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$72.9M |
Sector Composition
| 1 | Technology | 17.94% |
| 2 | Consumer Discretionary | 10.22% |
| 3 | Financials | 8.36% |
| 4 | Healthcare | 7.6% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Arcus Biosciences
RCUS
$1.23B
| $330K | ﹤0.01% |
10,462
-6,789
| -39% | -$214K |
|
|
WSR
2227
Whitestone REIT
WSR
$664M
| $329K | ﹤0.01% |
24,857
-5,792
| -19% | -$76.7K |
|
2228
SPDR DoubleLine Total Return Tactical ETF
TOTL
$3.89B
| $329K | ﹤0.01% |
7,356
+2,996
| +69% | +$134K |
|
2229
IAMGOLD
IAG
$6.42B
| $329K | ﹤0.01% |
107,403
-59,491
| -36% | -$182K |
|
2230
US Physical Therapy
USPH
$1.22B
| $329K | ﹤0.01% |
3,311
-4,337
| -57% | -$431K |
|
2231
Par Pacific Holdings
PARR
$1.67B
| $329K | ﹤0.01% |
25,239
-10,289
| -29% | -$134K |
|
2232
QuinStreet
QNST
$930M
| $328K | ﹤0.01% |
28,309
+5,207
| +23% | +$60.4K |
|
2233
Unitil
UTL
$827M
| $326K | ﹤0.01% |
6,530
-4,077
| -38% | -$203K |
|
2234
BJ's Restaurants
BJRI
$684M
| $325K | ﹤0.01% |
11,467
-17,528
| -60% | -$496K |
|
|
SAFE
2235
DELISTED
Safehold Inc.
SAFE
| $324K | ﹤0.01% |
5,845
-4,379
| -43% | -$243K |
|
|
NTUS
2236
DELISTED
Natus Medical Inc
NTUS
| $323K | ﹤0.01% |
12,305
-11,086
| -47% | -$291K |
|
2237
Apellis Pharmaceuticals
APLS
$3.14B
| $323K | ﹤0.01% |
6,351
-8,586
| -57% | -$436K |
|
2238
Veracyte
VCYT
$2.43B
| $322K | ﹤0.01% |
11,695
-14,270
| -55% | -$393K |
|
2239
BGC Group
BGC
$4.82B
| $319K | ﹤0.01% |
72,404
-76,320
| -51% | -$336K |
|
2240
AtriCure
ATRC
$1.74B
| $317K | ﹤0.01% |
4,829
-4,722
| -49% | -$310K |
|
2241
Enviri
NVRI
$983M
| $315K | ﹤0.01% |
25,741
-20,183
| -44% | -$247K |
|
2242
Upland Software
UPLD
$71.6M
| $314K | ﹤0.01% |
17,823
+5,944
| +50% | +$105K |
|
2243
Sinclair Inc
SBGI
$972M
| $314K | ﹤0.01% |
11,200
-12,259
| -52% | -$343K |
|
2244
Pilgrim's Pride
PPC
$10.4B
| $314K | ﹤0.01% |
12,492
-96,030
| -88% | -$2.41M |
|
2245
Invesco Mortgage Capital
IVR
$502M
| $310K | ﹤0.01% |
13,611
-9,336
| -41% | -$213K |
|
2246
iShares Europe ETF
IEV
$2.34B
| $309K | ﹤0.01% |
6,151
-17,458
| -74% | -$877K |
|
|
RUBY
2247
DELISTED
Rubius Therapeutics, Inc
RUBY
| $307K | ﹤0.01% |
55,785
+38,998
| +232% | +$215K |
|
2248
Hawkins
HWKN
$3.62B
| $307K | ﹤0.01% |
6,686
-3,298
| -33% | -$151K |
|
2249
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.76B
| $306K | ﹤0.01% |
+11,811
| New | +$306K |
|
2250
Q32 Bio
QTTB
$23.5M
| $306K | ﹤0.01% |
5,592
-956
| -15% | -$52.3K |
|